word,tfidf
month,5.787621554642601
week,2.723141812056815
12,2.210393696686641
day,1.8071843586189988
response,1.5390542937628282
defined,1.4950468894063245
24,1.4901694777467687
months,1.2870219912087935
disease,1.147263564402262
graft,1.1032502271599727
incidence,1.0797735765637992
criteria,0.9729895777046248
according,0.9649772324879381
16,0.9073388192604677
versus,0.8920147345324674
host,0.8920147345324674
events,0.8808623126164752
time,0.8225457867564676
48,0.8160292098477047
remission,0.8078282590935327
relapse,0.8000810863939355
days,0.7947804523509299
rate,0.7828868610777999
adverse,0.7734475101996846
grade,0.7647818663210724
inclusion,0.735587242377248
21,0.7315293992785916
cells,0.7217273163956548
using,0.7165029283555244
compared,0.6877207518462194
post,0.6792549859394009
analysis,0.6642740804783928
transplantation,0.656446042120754
cardiac,0.6452789004400935
survival,0.6367206619730956
hospitalization,0.625282377803459
blood,0.6179064609294328
overall,0.5989458412699191
vascular,0.5906117518960017
secondary,0.5896441512678832
36,0.5803711323233307
following,0.5774068612872146
baseline,0.5702711999803824
endpoint,0.5551505996955917
100,0.5544273555806681
pga,0.548754798837056
assessed,0.5408202555719348
follow,0.5384297974525163
lesions,0.5366504207011717
primary,0.5339648999620012
complete,0.5316939691546297
progression,0.5278004809845688
non,0.5204831804903589
best,0.5200179223926114
lung,0.5159617044937365
90,0.5156990124837972
30,0.513195102971791
first,0.5124178419619442
see,0.5116994595688655
new,0.5032608280570151
weeks,0.5012734488716976
chronic,0.5000984113068231
transplant,0.4981583684930869
life,0.49258054278201896
without,0.48612199086910396
22,0.48237209352686966
scale,0.4780740489221305
quality,0.4776505127692197
imaging,0.4772340751483341
number,0.47551945390844885
syndrome,0.46696398097197983
score,0.4632595747886849
actg,0.4571470501260002
severe,0.45393025529827324
rates,0.45029781749785963
20,0.4455394190286281
result,0.44277563213641524
acute,0.4416089687670469
standard,0.44021999120279964
evaluated,0.4342178960810522
changes,0.43396181646822446
estimated,0.43080629993275144
cell,0.41578697793562186
prednisone,0.41406018592391663
date,0.4062568890114701
25,0.40508186835487014
toxicity,0.4041137094348908
function,0.39682310228191997
infusion,0.39291246954243425
event,0.38947212549810273
60,0.3893339235753842
safety,0.3892095726030911
15,0.3834221187346339
endpoints,0.37349882634140275
informative,0.36945237659538704
engraftment,0.36924312784400476
common,0.3669858953739862
terminology,0.3669858953739862
performed,0.36549168679452765
occurrence,0.3616933772992009
chimerism,0.36128350305238527
randomization,0.35781830156608047
improvement,0.3567057604117062
magnetic,0.3540423826154108
resonance,0.3540423826154108
least,0.35200767735482874
within,0.3504398093615367
for,0.3502267494152381
arm,0.3471476158100905
anti,0.34065240969460503
kidney,0.33611659855674286
platelets,0.33526759976962445
free,0.33331102492989095
priors,0.3318227282809507
related,0.33128134287718747
retinal,0.3292585354120018
neutrophil,0.3282289963840638
tumor,0.3270430114605244
consecutive,0.32474561870527063
models,0.3192795121761386
vasculitis,0.31278302187667023
one,0.31012311299536544
failure,0.30755210752739603
neutrophils,0.306125457272483
count,0.30518676250293053
centralized,0.304803209113404
reading,0.304803209113404
composite,0.3046062170678585
blinded,0.3027441254427258
renal,0.3004827283665324
visit,0.3002443175944328
normalization,0.2995994930402527
start,0.2958640121941609
recorded,0.2958640121941609
target,0.29396516969331243
19,0.29238185247041
clinically,0.29111993280387816
health,0.2864437127703253
central,0.2856435861499045
partial,0.28508858192063874
reappearance,0.28112960737040393
beta,0.28019965189130525
resolution,0.27951971105630713
dose,0.27832751798535676
efficacy,0.2776685336236976
mean,0.2767339743230429
reactive,0.27469400561380863
protein,0.27469400561380863
every,0.27395365697267027
proteinuria,0.2738827330692396
questionnaire,0.27307258008190594
levels,0.272283969754861
last,0.26986881840118226
eye,0.26875242813097744
increase,0.26872221079686337
evaluation,0.26859678022773387
definition,0.2680394140892167
filtration,0.2668673217293553
cancer,0.2667961511405177
parameters,0.2655437499363927
glomerular,0.26541182081152126
prednisolone,0.26069161052208345
transfusion,0.25856664327114337
milligrams,0.2573977498944788
cd,0.2548893789676034
borr,0.2547896291437436
system,0.25475786027632275
mdrd,0.25426675260698317
skin,0.25426018951049495
level,0.2536932138644375
sf,0.2533518037287362
specific,0.24978242850656102
occurs,0.24855870219367227
of,0.24737887445847587
grading,0.2462385324234339
serum,0.24560198921954796
ventricular,0.24265254093268224
therapy,0.2422863843733396
modified,0.24200588292346475
immune,0.2415059877980679
red,0.2404343315494488
assessment,0.23998295774544523
activity,0.23979975557507796
including,0.23903858443077905
appendix,0.23903265103407478
platelet,0.23752327424308747
infection,0.23752327424308747
treatments,0.2361029576721568
arms,0.23562415870214046
transfusions,0.23515320126663225
creatinine,0.23453499773390224
analyses,0.23424315863124906
50,0.23237394998458788
classification,0.23236198778221323
disappearance,0.23220985513446324
injection,0.23209285489628514
systemic,0.23186502399019102
involvement,0.2311414053846024
ks,0.2285735250630001
section,0.22768456068802134
pre,0.22533285346177123
change,0.22484694166459385
stromal,0.223061826924906
mesenchymal,0.223061826924906
lymphocytes,0.2224712113855954
could,0.22135151609032477
considered,0.22054475595347617
expression,0.2201689055635962
end,0.2198326162209546
severity,0.21776561856741683
nk,0.21602808663025025
decrease,0.21424805798163105
mortality,0.21294759613449765
left,0.21237309524278708
nervous,0.2093867205163697
worsening,0.2070866167968723
cause,0.2067899892996799
uveitis,0.2044599251284322
hematopoietic,0.20379354318295986
index,0.20120071327163544
steroids,0.20114334127574715
reconstitution,0.1988656151288744
percentage,0.19479419119618413
laboratory,0.19436684736194446
absolute,0.19267608876635572
ct,0.19250135527707227
samples,0.19040023009596307
behcets,0.19018087555012309
bd,0.19018087555012309
bayesian,0.18959845354257868
beginning,0.18939798451343132
symptoms,0.18845250458097418
appearance,0.18746224888184354
documented,0.18560131064658902
two,0.18365107087250795
others,0.18343681740491052
normal,0.18241189673266647
dna,0.1809933650140274
leukemic,0.1802737785205432
infections,0.18016000635462456
binomial,0.17985392305280837
uniform,0.17985392305280837
surface,0.17969140403042533
sct,0.1788483079968833
ii,0.17693939295607497
haze,0.1768259679320205
year,0.1758997433746448
scan,0.17546600321150468
coherence,0.1745054769249683
optical,0.1745054769249683
intravenous,0.17384136977499934
death,0.1722105097330618
measured,0.1721622311636447
cd4,0.17173806198477165
cd8,0.17173806198477165
independent,0.16870038586616218
case,0.1676465752750957
visual,0.16710503835212148
absence,0.16632830556984035
v5,0.16538528526112328
measures,0.16416716123226407
rectal,0.1640846558367467
150,0.1640846558367467
toxicities,0.16306656714414483
requiring,0.16197636370092272
equal,0.16164770471098108
national,0.16127014788571759
collection,0.1607793570938045
maximum,0.16075334871220098
peripheral,0.16045638787841857
pcr,0.16016181315674363
alive,0.1599108670058147
10,0.15984945323032432
associated,0.15950481432965477
tomography,0.15949922826217847
biological,0.15919444198687976
concentration,0.15805476866016718
markers,0.15630408333992424
proportion,0.15619571938412607
recurrence,0.15573659596969694
early,0.15326244890927998
ctc,0.15323767156456838
confirmed,0.1524763937217164
plasma,0.15204683976243918
either,0.15156168141332235
de,0.15131316519461552
drug,0.15098471491347198
institute,0.14991514340410067
data,0.14951725890895984
thickness,0.14926190021994568
randomized,0.1490164231667976
ctae,0.1482998693247972
cumulative,0.14829155023452234
biologically,0.14810383447285141
duration,0.14799532254329184
delay,0.14711256226879074
subjects,0.14501340251720266
limited,0.14449857276036768
stem,0.14428343967902818
described,0.14299598860995966
iii,0.14205470997777866
active,0.14140606198318428
fever,0.14111536895284857
flare,0.1407319493031751
kilograms,0.14058752188852122
hours,0.13989306338644392
point,0.13932299382455776
length,0.13905628528217034
group,0.13905628528217034
numbers,0.13892019457951976
adapted,0.1374258620641854
interval,0.13731771118807792
discontinuation,0.136696111059677
5g,0.13615051289331792
moderate,0.13567494253481624
prior,0.13524890118168928
phase,0.13490518903248694
ferritin,0.13480146060590442
refractory,0.13413883166694293
estimator,0.1338282178932466
hemolytic,0.1337528302626291
right,0.13372063210762003
18,0.13364493813509506
features,0.1333617644407245
sclerosis,0.13334162795771054
donor,0.13308736457921977
acuity,0.1330661779400698
corrected,0.1330661779400698
included,0.13102178341752424
ocular,0.1308773731935837
physical,0.13007293569000952
hospital,0.12970177510479297
grfs,0.12949135613268398
organs,0.1271381628067102
corticosteroid,0.12670670666079864
vitreous,0.1264207730719803
med,0.1264152744619523
profile,0.1254454233852578
whole,0.12434596518069341
curve,0.12434596518069341
increased,0.12384170226037719
main,0.12361658884691049
consumption,0.1228213594530385
except,0.12280007294556097
investigator,0.1227609385318711
nih,0.12229332848809417
magic,0.12229332848809417
value,0.12194461298540787
biopsy,0.12187563443962998
impact,0.12137189123888212
rank,0.12128500178843446
amplification,0.12093629341469989
involved,0.1198539200946297
version,0.1190427064918193
clinic,0.1190427064918193
sample,0.11887720974402165
quantification,0.11887720974402165
virological,0.11887720974402165
unit,0.11802178237637713
gastrointestinal,0.11780470275937117
ebv,0.1164241671022733
cmv,0.1164241671022733
test,0.11623605346124191
monitoring,0.11616466265767572
digestive,0.11610879071209626
interaction,0.11572736361870889
macular,0.11234479394747804
cost,0.11209371554943705
measure,0.11156881663107959
gammaglobulines,0.11135801398612118
counts,0.11134030949673705
additional,0.11107337274209837
terms,0.11104690341429374
lymphedema,0.11104690341429374
ctep,0.11104690341429374
gov,0.11104690341429374
scored,0.11104690341429374
gamma,0.11073721737750733
form,0.11061102652905819
min,0.11046452940305157
years,0.10970802736782109
per,0.10953604224278171
use,0.1088631863059883
meier,0.10874178568362235
kaplan,0.10874178568362235
extensive,0.1075472932271126
physician,0.10698963036735758
course,0.10697249609265091
care,0.10656098742047196
effects,0.10645986522826345
side,0.10645986522826345
24h,0.10626234201301754
frequency,0.10597062866751422
tolerability,0.10597062866751422
evidence,0.105727471249778
sparing,0.10537331677761544
second,0.10530129283962289
present,0.10473003974902921
preexisting,0.10379246746801468
analyzed,0.10362144655286361
trials,0.10306737901013611
inflammation,0.10199581867054193
pulmonary,0.10147682811346208
chest,0.101206329989185
nomenclature,0.10082278560006172
standardization,0.10082278560006172
38,0.10081109368478444
eortc,0.10032496418605465
factors,0.10032496418605465
c30,0.10032496418605465
qlq,0.10032496418605465
v3,0.10032496418605465
total,0.09945285950544863
presence,0.09896111288059295
lymphocyte,0.09879861834793259
clearance,0.09850980634626144
medical,0.09796004065688096
discretion,0.09773256797729475
cerebral,0.09730278800660538
status,0.09728034575425883
analyzing,0.09602777067089571
collected,0.09486158502897368
loss,0.09415771886566576
initiation,0.09359547339458026
myeloid,0.09346104479964962
du,0.09332629146165825
evolution,0.09330378229091546
bone,0.09210695897199689
abdominal,0.09187370535263428
onset,0.091774931174915
consortium,0.09156580702760028
2016,0.09156580702760028
criterion,0.09136414253293151
potential,0.09000967748982755
treated,0.0899588348831197
previous,0.08948777166030752
percent,0.08943807420868521
meeting,0.08943807420868521
targets,0.08943807420868521
edema,0.08943807420868521
survey,0.08924136343312629
troponin,0.08920148309316583
neurological,0.08920148309316583
responder,0.0888272956044269
chosen,0.08857697119947133
arthritis,0.08750557104589093
pains,0.08750557104589093
endoscopy,0.08750557104589093
300,0.08725273846248414
microns,0.08725273846248414
250,0.08600718221386194
manifestations,0.08590199064267437
line,0.08562363615732493
regulatory,0.08562363615732493
courses,0.08562363615732493
censored,0.0855686137116581
echocardiography,0.08488946624271274
anemia,0.08468429513239484
acquired,0.08468429513239484
47,0.08442991936929543
based,0.08348403708700855
investigators,0.08311134096044638
electrolytes,0.08311134096044638
reduction,0.08230992858815961
unblinded,0.0822928715420349
determined,0.0817607528651311
body,0.08173054446464803
creatininuria,0.08149764214816292
usual,0.08122888003699867
distribution,0.08021486062999866
achieving,0.08008090657837182
stage,0.0792232530609122
results,0.07853501434323937
underlying,0.0784925722560938
chamber,0.0784925722560938
anterior,0.0784925722560938
95,0.07815577695932041
perform,0.07809771530427254
santé,0.07719243521126433
different,0.07680518886400514
global,0.07680518886400514
pain,0.07531267681567136
considering,0.07366883784112872
paraclinical,0.07349333575453444
reactants,0.07349333575453444
highest,0.07349333575453444
bilateral,0.07349333575453444
esr,0.07349333575453444
current,0.07349333575453444
serious,0.0732856930517298
allo,0.07274661319215943
inflammatory,0.07232574338095055
gammaglobulin,0.07212777300669775
complications,0.07212777300669775
enzymes,0.07118843198176765
neuropathy,0.07118843198176765
leakage,0.07107932186572023
angiography,0.07107932186572023
vessel,0.07107932186572023
tyndall,0.07107932186572023
17,0.07082526035836431
tnfa,0.07082526035836431
measurement,0.07082526035836431
intervals,0.07062554743364997
observed,0.07062554743364997
define,0.0697496554372228
extra,0.06861098555011663
treat,0.06842135636475395
follows,0.06767164452518654
volume,0.06687641513131455
bilirubin,0.06687641513131455
thoracic,0.06687641513131455
scales,0.06623286798064168
world,0.06599179823842725
tolerated,0.06599179823842725
toxic,0.06599179823842725
attacks,0.06599179823842725
international,0.06599179823842725
organization,0.06599179823842725
degree,0.06599179823842725
reasons,0.0656125608545083
whether,0.0656125608545083
immunological,0.06533468083750653
phosphatase,0.06481733146063631
alkaline,0.06481733146063631
intensive,0.06481733146063631
gt,0.06481733146063631
liver,0.06481733146063631
detection,0.06426197275919301
sub,0.06426197275919301
stored,0.06346674336532103
reaction,0.06346674336532103
used,0.06346674336532103
need,0.06321533230940798
nephritis,0.06303789532996382
steroid,0.06255176583123404
mass,0.0611256217363166
may,0.0611256217363166
points,0.0596282235639703
remissions,0.05890235137968559
affected,0.05890235137968559
articular,0.05890235137968559
ulcers,0.05890235137968559
seen,0.05890235137968559
allogeneic,0.05808233132883786
fact,0.05606776944530452
previously,0.05538556392310448
intent,0.05512842842037442
consider,0.05512842842037442
combined,0.05512842842037442
sponsor,0.05512842842037442
also,0.054590334529232495
relapses,0.053906946881919215
values,0.05344858213361514
step,0.05318884504037992
committee,0.053069344749696185
continuous,0.05297155003429027
control,0.052176320640418286
include,0.0517187566543809
cytometry,0.0517187566543809
assess,0.0517187566543809
activation,0.0517187566543809
weight,0.049377635025376475
1g,0.049055902680606854
hematuria,0.049055902680606854
complement,0.049055902680606854
c4,0.049055902680606854
corticosteroids,0.049055902680606854
doubling,0.049055902680606854
judgment,0.049055902680606854
positive,0.04553911522402575
36v2,0.04553911522402575
daily,0.04553911522402575
antigen,0.04553911522402575
human,0.04553911522402575
short,0.04553911522402575
leukocyte,0.04553911522402575
antibodies,0.04553911522402575
nationale,0.04474388583015376
cytokines,0.04474388583015376
des,0.04474388583015376
paris,0.04474388583015376
urine,0.04474388583015376
et,0.04474388583015376
sécurité,0.04474388583015376
agence,0.04474388583015376
medicament,0.04474388583015376
produits,0.04474388583015376
aggravation,0.04474388583015376
us,0.04284234781829236
moreover,0.03299589911921363
doses,0.03299589911921363
